Coming to work at PhRMA a year and a half ago required a bit of a crash course in the incredibly complex and always evolving biopharmaceutical research sector. In that time, I’ve come to learn that many industry critics seek to generalize (and sometimes mischaracterize) the development of new medicines, our sector’s commitment to safety and the role of investment. And if one thing is true about biopharmaceutical research, it’s that the...
- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Research
- About


The PhRMA Foundation recently announced its 2012 award recipients and one, Lindsay Garvin, is right in our backyard from the 




